Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by imatryinon Dec 14, 2017 7:59am
149 Views
Post# 27154071

RE:RE:RE:New Math

RE:RE:RE:New MathWe are in tax loss season and there are those that bought above yesterday's price earlier in the year and want that loss, so not surprising it didn't go up much. And with the 30 day rule to buy back in after tax loss selling, their window of opportunity to buy back before FDA approval closes rapidly. 

And there are those that are still trying to acquire more at a lower cost so when the volume dries up, they succeed in bringing the few cent gain back down.  We still don't have a lot of volume so it is easy to do. With the FDA's approval looming, I believe the SP will start to jump next week.  I'm hopeful we will see a hold or small gain today and tomorrow as well.  

PezDalatoYou wrote: I hope that you are right. I was a little disappointed today that the sp didn't move up much on what was good news.


Bullboard Posts